• Toggle Accessibility Statement
  • Home
  • Skip to Main Content
  • Sitemap
Menu
GOVPH
  • Home
  • About Us
    • The Pharmaceutical Division
    • Calendar of Events
  • Our Programs
    • COVID 19
    • Medicines Policy and Research
      • Advisory Council for the Implementation of RA 9502
      • Policy Dialogue on Universal Healthcare and Access to Medicines
      • Progress Report for the Implementation of the Cheaper Medicines Act of 2008
      • Research Management
    • Drug Pricing
      • Drug Price Database
      • Price Negotiation Board
      • Mark-up Regulation of Essential Medicines in DOH Facilities
    • Suggested Retail Price (SRP) for Selected Essential Emergency Medicines and Medical Devices
    • Botika ng Bayan and Botika ng Bayani
    • Rational Use of Medicines
      • Philippine National Formulary
      • DOH Program on Combating Antimicrobial Resistance
      • Active Drug Safety Monitoring and Management (aDSM) Program
  • Documents and Issuances
    • Laws
    • Official Issuances
    • Researches
    • Official Publications
      • Drug Price Reference Index Booklet
      • National Antibiotic Guidelines
      • The Philippine Action Plan to Combat Antimicrobial Resistance 2019-2023
      • Philippine National Formulary
      • Progress Report
  • Media Gallery
  • Links
  • AUXILIARY MENU
  • GOVPH
  • Home
  • About Us
    • The Pharmaceutical Division
    • Calendar of Events
  • Our Programs
    • COVID 19
    • Medicines Policy and Research
      • Advisory Council for the Implementation of RA 9502
      • Policy Dialogue on Universal Healthcare and Access to Medicines
      • Progress Report for the Implementation of the Cheaper Medicines Act of 2008
      • Research Management
    • Drug Pricing
      • Drug Price Database
      • Price Negotiation Board
      • Mark-up Regulation of Essential Medicines in DOH Facilities
    • Suggested Retail Price (SRP) for Selected Essential Emergency Medicines and Medical Devices
    • Botika ng Bayan and Botika ng Bayani
    • Rational Use of Medicines
      • Philippine National Formulary
      • DOH Program on Combating Antimicrobial Resistance
      • Active Drug Safety Monitoring and Management (aDSM) Program
  • Documents and Issuances
    • Laws
    • Official Issuances
    • Researches
    • Official Publications
      • Drug Price Reference Index Booklet
      • National Antibiotic Guidelines
      • The Philippine Action Plan to Combat Antimicrobial Resistance 2019-2023
      • Philippine National Formulary
      • Progress Report
  • Media Gallery
  • Links
    • Accessibility Statement
    • High Contrast
    • Skip to Content
    • Skip to Footer

Government-Mediated Access Price (GMAP) Adjustment of Co-Amoxiclav Preparations

Department Circular 2021-0088 Related Posts Mark-up Regulation of Essential Medicines in DOH Facilities 07 Oct 2020 Drug Price Reference Index 07 Oct 2020 Maximum Retail Price of Drugs and Medicines continue reading : Government-Mediated Access Price (GMAP) Adjustment of Co-Amoxiclav Preparations

DOH, PhilHealth, DTI Sign JAO on Pricing Negotiations for Single-Sourced Health Commodities (Press Release)

Related Posts Mark-up Regulation of Essential Medicines in DOH Facilities 07 Oct 2020 Drug Price Reference Index 07 Oct 2020 Maximum Retail Price of Drugs and Medicines 14 Sep 2020 continue reading : DOH, PhilHealth, DTI Sign JAO on Pricing Negotiations for Single-Sourced Health Commodities (Press Release)